What does JONA PHARMA do?

JONA PHARMA is filed with the CBE under the catch-all “Overige detailhandel in voedingsmiddelen”. Also registered: perfumery. Private Limited, started on 1 June 2012, 1 establishment.

What is the address of JONA PHARMA?

The registered office of JONA PHARMA is located at Dorpstraat 61 box A, 9140 Temse.

Is JONA PHARMA still active?

Yes. According to the CBE (1 October 2026) JONA PHARMA is active, legal situation “Normale toestand”, started on 1 June 2012.

Is JONA PHARMA registered on Peppol?

Yes, JONA PHARMA is registered on the Peppol network with ID 0208:0846278181.

What is the enterprise number of JONA PHARMA?

The enterprise number of JONA PHARMA is BE0846278181.

When was JONA PHARMA founded?

JONA PHARMA was founded on 1 June 2012.

Who are the directors of JONA PHARMA?

According to the 2025 annual accounts, the directors of JONA PHARMA are: JOHAN VAN DAELE.

Is JONA PHARMA a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 1 June 2012; 5 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did JONA PHARMA make in 2025?

JONA PHARMA posted a profit after taxes of € 3 in financial year 2025.

What is the revenue of JONA PHARMA?

As a small company, JONA PHARMA is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 1,199.

JONA PHARMA (Private Limited) - Temse - BE0846278181

Dossier JONA PHARMA, printed on 1 October 2026 from databakkes.be/en/0846278181/jona-pharma. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

JONA PHARMA from Temse, company number BE0846278181, closed financial year 2025 with a result of € 3 after tax. For that financial year JONA PHARMA recorded a gross margin of € 1,199 and equity of € 21,435. Compared with financial year 2024, the result moved from € 15 to € 3. The company is profitable. The buffer is growing. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.

What it is worth Growing

€ 21,435

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Healthy

€ 3

▼ 81% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 1,298

▼ 38% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Growing

Stays in the company

No dividend for 2025. Retained profit grew to € 15,235.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

€ 25,000

Loans from banks and other lenders, long and short.

Owed to suppliers

€ 9,332

▲ 179% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes

€ 1,542

▲ 16% vs 2024

Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 6,190 Gross margin 2022: € 6,190 First fiscal year in the series	€ 2,416 Gross margin 2023: € 2,416 ▼ 61% vs 2022 (€ 6,190) Unfavourable step	€ 1,765 Gross margin 2024: € 1,765 ▼ 27% vs 2023 (€ 2,416) Unfavourable step	€ 1,199 Gross margin 2025: € 1,199 ▼ 32% vs 2024 (€ 1,765) Unfavourable step	▼ 32%
Profit after taxes	€ 149 Profit after taxes 2022: € 149 First fiscal year in the series	€ 10 Profit after taxes 2023: € 10 ▼ 94% vs 2022 (€ 149) Unfavourable step	€ 15 Profit after taxes 2024: € 15 ▲ 61% vs 2023 (€ 10) Favourable step	€ 3 Profit after taxes 2025: € 3 ▼ 81% vs 2024 (€ 15) Unfavourable step	▼ 81%
Equity	€ 21,408 Equity 2022: € 21,408 First fiscal year in the series	€ 21,417 Equity 2023: € 21,417 Unchanged (€ 21,408) Favourable step	€ 21,433 Equity 2024: € 21,433 Unchanged (€ 21,417) Favourable step	€ 21,435 Equity 2025: € 21,435 Unchanged (€ 21,433) Favourable step
Total debts	€ 92,207 Total debts 2022: € 92,207 First fiscal year in the series	€ 97,430 Total debts 2023: € 97,430 ▲ 6% vs 2022 (€ 92,207) Unfavourable step	€ 90,817 Total debts 2024: € 90,817 ▼ 7% vs 2023 (€ 97,430) Favourable step	€ 101,175 Total debts 2025: € 101,175 ▲ 11% vs 2024 (€ 90,817) Unfavourable step	▲ 11%
Cash	€ 347 Cash 2022: € 347 First fiscal year in the series	€ 3,867 Cash 2023: € 3,867 ▲ € 3,520 vs 2022 (€ 347) Favourable step	€ 2,078 Cash 2024: € 2,078 ▼ 46% vs 2023 (€ 3,867) Unfavourable step	€ 1,298 Cash 2025: € 1,298 ▼ 38% vs 2024 (€ 2,078) Unfavourable step	▼ 38%
Retained profit	€ 15,208 Retained profit 2022: € 15,208 First fiscal year in the series	€ 15,217 Retained profit 2023: € 15,217 Unchanged (€ 15,208) Favourable step	€ 15,233 Retained profit 2024: € 15,233 Unchanged (€ 15,217) Favourable step	€ 15,235 Retained profit 2025: € 15,235 Unchanged (€ 15,233) Favourable step
Bank debt	€ 25,000 Bank debt 2022: € 25,000 First fiscal year in the series	€ 25,000 Bank debt 2023: € 25,000 Unchanged (€ 25,000) Unchanged	€ 25,000 Bank debt 2024: € 25,000 Unchanged (€ 25,000) Unchanged	€ 25,000 Bank debt 2025: € 25,000 Unchanged (€ 25,000) Unchanged
Balance sheet total	€ 113,615 Balance sheet total 2022: € 113,615 First fiscal year in the series	€ 118,847 Balance sheet total 2023: € 118,847 ▲ 5% vs 2022 (€ 113,615) Unchanged	€ 112,249 Balance sheet total 2024: € 112,249 ▼ 6% vs 2023 (€ 118,847) Unchanged	€ 122,611 Balance sheet total 2025: € 122,611 ▲ 9% vs 2024 (€ 112,249) Unchanged	▲ 9%

Key figures of JONA PHARMA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to JONA PHARMA?

What happened at JONA PHARMA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Sep 30, 2026 New annual accounts for financial year 2025: profit of € 3 (▼ 81% vs 2024). filed late Source: NBB ↗
Jun 1, 2012 New establishment in Temse. KBO
Jun 1, 2012 Start of the company according to the CBE. KBO

In short

From € 149 profit in 2022 to € 3 profit in 2025.

Paid € 1,664 in corporate taxes since 2022.

Best year ever: 2022, with € 149 profit.

Original PDFs at the National Bank ↗

A new publication or filing at JONA PHARMA? We notify you, reason included.

Follow JONA PHARMA

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

JOHAN VAN DAELE

JONA PHARMA

Behind JONA PHARMA is JOHAN VAN DAELE.

See the full network in the app

Directors

According to the 2025 annual accounts

JOHAN VAN DAELE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpstraat 61 box A

9140 Temse

2.210.958.909

Dorpstraat 61 A

9140 Temse

Active since 1 June 2012

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 1 companies are registered at this address.

All companies at this address →

Apotheek Van Wambeke

€ 155,445 gross margin · 2025

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0846.278.181

VAT number

BE 0846.278.181

Registered office

Dorpstraat 61 bus A, 9140 Temse

Names & denominations

JONA PHARMA

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Normale toestand

Start date

1 June 2012

Peppol

Active · Active since 5 Oct 2025

Activities · NACE

Overige detailhandel in voedingsmiddelen, neg

Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies

Detailhandel in cosmetica en toiletartikelen

View on CBE Public ↗ Annual accounts (NBB) ↗

JONA PHARMA

Financials

What happened to JONA PHARMA?

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions